Our results demonstrated that the down‐regulation of miR‐497 could inhibit the levels of IGF1R/IRS1 signal pathway‐related proteins in TMZ‐resistant glioma cells both in vitro and in vivo. This evidence concerns the gene IRS1 and glioma.